Douglas Emmet Drachman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peripheral Arterial Disease | 15 | 2024 | 1304 | 1.360 |
Why?
|
| Drug-Eluting Stents | 6 | 2021 | 681 | 1.340 |
Why?
|
| Angioplasty, Balloon | 5 | 2019 | 593 | 1.290 |
Why?
|
| Lower Extremity | 9 | 2024 | 1217 | 1.240 |
Why?
|
| Ischemia | 6 | 2023 | 1900 | 1.000 |
Why?
|
| Cardiology | 11 | 2024 | 1702 | 0.970 |
Why?
|
| Femoral Artery | 4 | 2019 | 829 | 0.960 |
Why?
|
| Stents | 12 | 2017 | 3197 | 0.930 |
Why?
|
| Limb Salvage | 4 | 2023 | 489 | 0.790 |
Why?
|
| American Heart Association | 7 | 2024 | 1050 | 0.670 |
Why?
|
| Radial Artery | 3 | 2019 | 188 | 0.650 |
Why?
|
| Popliteal Artery | 3 | 2019 | 313 | 0.620 |
Why?
|
| Coronary Restenosis | 3 | 2009 | 396 | 0.620 |
Why?
|
| Veins | 1 | 2023 | 769 | 0.620 |
Why?
|
| Vascular Diseases | 3 | 2017 | 1162 | 0.620 |
Why?
|
| Endovascular Procedures | 8 | 2021 | 2217 | 0.600 |
Why?
|
| Arteries | 1 | 2023 | 1127 | 0.590 |
Why?
|
| Education, Medical, Continuing | 2 | 2021 | 829 | 0.580 |
Why?
|
| Extremities | 1 | 2023 | 870 | 0.570 |
Why?
|
| Education, Distance | 1 | 2021 | 260 | 0.570 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2017 | 308 | 0.560 |
Why?
|
| Tunica Intima | 2 | 2014 | 459 | 0.560 |
Why?
|
| Cholecystitis | 1 | 2017 | 181 | 0.540 |
Why?
|
| Paclitaxel | 4 | 2021 | 1733 | 0.520 |
Why?
|
| Cardiovascular Agents | 2 | 2021 | 849 | 0.520 |
Why?
|
| Coronary Angiography | 5 | 2020 | 4541 | 0.520 |
Why?
|
| Congresses as Topic | 1 | 2021 | 812 | 0.520 |
Why?
|
| Cholelithiasis | 1 | 2017 | 408 | 0.510 |
Why?
|
| Gallbladder | 1 | 2017 | 308 | 0.510 |
Why?
|
| Ankle Brachial Index | 1 | 2015 | 163 | 0.470 |
Why?
|
| Renal Artery Obstruction | 2 | 2013 | 217 | 0.460 |
Why?
|
| Hemorrhage | 3 | 2019 | 3466 | 0.450 |
Why?
|
| Coronary Artery Disease | 7 | 2019 | 6568 | 0.430 |
Why?
|
| Intestine, Large | 1 | 2012 | 69 | 0.420 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2014 | 311 | 0.410 |
Why?
|
| Inservice Training | 1 | 2015 | 375 | 0.410 |
Why?
|
| Angioplasty | 2 | 2012 | 356 | 0.400 |
Why?
|
| Vena Cava Filters | 1 | 2015 | 270 | 0.400 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2012 | 93 | 0.400 |
Why?
|
| Splanchnic Circulation | 1 | 2012 | 122 | 0.400 |
Why?
|
| Certification | 1 | 2015 | 420 | 0.380 |
Why?
|
| Renal Artery | 1 | 2013 | 354 | 0.380 |
Why?
|
| Device Removal | 1 | 2015 | 643 | 0.350 |
Why?
|
| Chest Pain | 1 | 2017 | 1101 | 0.350 |
Why?
|
| Coronary Occlusion | 1 | 2013 | 306 | 0.340 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2014 | 1724 | 0.330 |
Why?
|
| Cardiac Tamponade | 1 | 2010 | 175 | 0.320 |
Why?
|
| Vascular Surgical Procedures | 2 | 2015 | 1508 | 0.320 |
Why?
|
| Radiography, Interventional | 2 | 2014 | 1131 | 0.320 |
Why?
|
| Myocardial Ischemia | 2 | 2017 | 2138 | 0.320 |
Why?
|
| Advisory Committees | 4 | 2017 | 796 | 0.320 |
Why?
|
| Coronary Stenosis | 1 | 2014 | 802 | 0.310 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2010 | 125 | 0.310 |
Why?
|
| Pericardial Effusion | 1 | 2010 | 246 | 0.310 |
Why?
|
| Carotid Stenosis | 4 | 2016 | 859 | 0.290 |
Why?
|
| Exercise Test | 1 | 2015 | 2186 | 0.280 |
Why?
|
| Recombinant Proteins | 2 | 2016 | 6512 | 0.280 |
Why?
|
| Coronary Vessels | 2 | 2015 | 3124 | 0.270 |
Why?
|
| Carotid Artery Diseases | 1 | 2012 | 879 | 0.260 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 1321 | 0.260 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2006 | 56 | 0.250 |
Why?
|
| Catheterization, Peripheral | 2 | 2019 | 347 | 0.250 |
Why?
|
| Vena Cava, Superior | 1 | 2006 | 197 | 0.240 |
Why?
|
| Treatment Outcome | 21 | 2022 | 65379 | 0.230 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2022 | 997 | 0.230 |
Why?
|
| Disease Management | 4 | 2017 | 2535 | 0.200 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 2599 | 0.190 |
Why?
|
| Clinical Competence | 3 | 2015 | 4858 | 0.180 |
Why?
|
| Humans | 58 | 2024 | 768171 | 0.180 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2017 | 489 | 0.180 |
Why?
|
| Societies, Medical | 5 | 2024 | 3968 | 0.170 |
Why?
|
| Drug Delivery Systems | 2 | 2002 | 2237 | 0.170 |
Why?
|
| Registries | 5 | 2022 | 8375 | 0.150 |
Why?
|
| Cardiovascular Diseases | 2 | 2021 | 15662 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 4 | 2020 | 7454 | 0.140 |
Why?
|
| Endarterectomy | 1 | 2017 | 196 | 0.140 |
Why?
|
| Atherosclerosis | 1 | 2012 | 3433 | 0.130 |
Why?
|
| Embolic Protection Devices | 1 | 2016 | 43 | 0.130 |
Why?
|
| Constriction, Pathologic | 2 | 2017 | 1104 | 0.130 |
Why?
|
| Myocardial Infarction | 2 | 2014 | 11519 | 0.130 |
Why?
|
| Balloon Occlusion | 1 | 2016 | 129 | 0.130 |
Why?
|
| Hirudins | 1 | 2016 | 179 | 0.120 |
Why?
|
| Intracranial Embolism | 1 | 2016 | 188 | 0.120 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2002 | 2057 | 0.110 |
Why?
|
| Patient Readmission | 2 | 2018 | 3288 | 0.110 |
Why?
|
| Acute Coronary Syndrome | 2 | 2018 | 2194 | 0.110 |
Why?
|
| Consensus | 6 | 2019 | 3211 | 0.110 |
Why?
|
| Equipment Failure | 1 | 2015 | 585 | 0.100 |
Why?
|
| Tomography, Emission-Computed | 2 | 2015 | 1126 | 0.100 |
Why?
|
| Heart Arrest | 1 | 2022 | 1515 | 0.100 |
Why?
|
| Postoperative Hemorrhage | 1 | 2016 | 419 | 0.100 |
Why?
|
| Databases, Factual | 3 | 2018 | 8080 | 0.100 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2015 | 511 | 0.100 |
Why?
|
| Electric Countershock | 1 | 2015 | 534 | 0.100 |
Why?
|
| Cerebral Revascularization | 1 | 2015 | 260 | 0.100 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1991 | 31 | 0.100 |
Why?
|
| Heart Diseases | 2 | 2015 | 2819 | 0.100 |
Why?
|
| Nuclear Medicine | 1 | 2015 | 262 | 0.100 |
Why?
|
| Male | 19 | 2020 | 364731 | 0.100 |
Why?
|
| 4-Aminopyridine | 1 | 1991 | 81 | 0.090 |
Why?
|
| Coronary Aneurysm | 1 | 2014 | 234 | 0.090 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 1524 | 0.090 |
Why?
|
| Academies and Institutes | 1 | 2013 | 326 | 0.090 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2015 | 881 | 0.090 |
Why?
|
| Electrocardiography | 2 | 2017 | 6412 | 0.090 |
Why?
|
| Heparin | 2 | 2016 | 1636 | 0.090 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 5891 | 0.090 |
Why?
|
| Cross Infection | 1 | 2020 | 1425 | 0.090 |
Why?
|
| Time Factors | 11 | 2021 | 40220 | 0.090 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2017 | 2763 | 0.090 |
Why?
|
| United States | 17 | 2024 | 73039 | 0.090 |
Why?
|
| Endarterectomy, Carotid | 1 | 2015 | 556 | 0.080 |
Why?
|
| Hypertension, Renovascular | 1 | 2009 | 115 | 0.080 |
Why?
|
| Renal Dialysis | 1 | 2018 | 1791 | 0.080 |
Why?
|
| Sirolimus | 2 | 2009 | 1540 | 0.080 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2018 | 1250 | 0.080 |
Why?
|
| Potassium Channels | 1 | 1991 | 538 | 0.080 |
Why?
|
| Female | 18 | 2020 | 397187 | 0.080 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2018 | 1459 | 0.080 |
Why?
|
| Membrane Potentials | 1 | 1991 | 1090 | 0.080 |
Why?
|
| Lidocaine | 1 | 1991 | 546 | 0.080 |
Why?
|
| Bupivacaine | 1 | 1991 | 414 | 0.080 |
Why?
|
| Pipecolic Acids | 1 | 2008 | 77 | 0.070 |
Why?
|
| Risk Factors | 12 | 2021 | 74944 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6316 | 0.070 |
Why?
|
| Equipment Design | 1 | 2015 | 3522 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2017 | 6004 | 0.070 |
Why?
|
| Communication | 1 | 2021 | 3905 | 0.070 |
Why?
|
| Acute Disease | 1 | 2017 | 7243 | 0.070 |
Why?
|
| Alcoholism | 1 | 2017 | 1980 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 2298 | 0.070 |
Why?
|
| Education, Medical, Graduate | 2 | 2015 | 2420 | 0.070 |
Why?
|
| Coronary Disease | 1 | 2000 | 5919 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 2496 | 0.060 |
Why?
|
| Inflammation | 1 | 2005 | 10873 | 0.060 |
Why?
|
| Curriculum | 2 | 2015 | 3782 | 0.060 |
Why?
|
| Phlebography | 1 | 2006 | 326 | 0.060 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 1599 | 0.060 |
Why?
|
| Predictive Value of Tests | 5 | 2019 | 15453 | 0.060 |
Why?
|
| Vascular Patency | 2 | 2019 | 917 | 0.060 |
Why?
|
| Hospital Mortality | 4 | 2022 | 5349 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2016 | 5151 | 0.060 |
Why?
|
| Aged, 80 and over | 9 | 2018 | 59626 | 0.050 |
Why?
|
| Stroke | 3 | 2015 | 9755 | 0.050 |
Why?
|
| Heart Ventricles | 1 | 2015 | 3841 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2016 | 3007 | 0.050 |
Why?
|
| Hemodynamics | 2 | 2010 | 4194 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 13013 | 0.050 |
Why?
|
| Catheter Ablation | 1 | 2015 | 2780 | 0.050 |
Why?
|
| Immunosuppressive Agents | 2 | 2005 | 4206 | 0.040 |
Why?
|
| Patient Selection | 3 | 2018 | 4260 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2008 | 1179 | 0.040 |
Why?
|
| Ulnar Artery | 1 | 2019 | 15 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8747 | 0.040 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 2145 | 0.040 |
Why?
|
| Swine | 1 | 2009 | 5997 | 0.040 |
Why?
|
| Laboratories | 1 | 2022 | 463 | 0.040 |
Why?
|
| Postoperative Complications | 2 | 2018 | 15833 | 0.040 |
Why?
|
| Laboratories, Hospital | 1 | 2020 | 192 | 0.040 |
Why?
|
| Models, Animal | 1 | 2005 | 2122 | 0.040 |
Why?
|
| Critical Illness | 2 | 2021 | 2755 | 0.040 |
Why?
|
| Animals | 6 | 2014 | 169285 | 0.040 |
Why?
|
| Incidence | 4 | 2018 | 21538 | 0.040 |
Why?
|
| Punctures | 1 | 2018 | 372 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 2019 | 592 | 0.030 |
Why?
|
| Survival Rate | 2 | 2022 | 12840 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2014 | 24318 | 0.030 |
Why?
|
| Hand | 1 | 2021 | 913 | 0.030 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2019 | 745 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 1995 | 52 | 0.030 |
Why?
|
| Arrestins | 1 | 1995 | 73 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 1810 | 0.030 |
Why?
|
| Credentialing | 1 | 2015 | 114 | 0.030 |
Why?
|
| Mentors | 1 | 2020 | 671 | 0.030 |
Why?
|
| Polymers | 1 | 2002 | 1630 | 0.030 |
Why?
|
| Rabbits | 1 | 2000 | 4773 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2021 | 81760 | 0.030 |
Why?
|
| Risk Adjustment | 1 | 2017 | 599 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2018 | 1826 | 0.030 |
Why?
|
| Antithrombins | 1 | 2016 | 294 | 0.030 |
Why?
|
| Recurrence | 2 | 2009 | 8509 | 0.030 |
Why?
|
| Algorithms | 1 | 2014 | 14164 | 0.030 |
Why?
|
| Aged | 8 | 2018 | 171502 | 0.030 |
Why?
|
| Morbidity | 1 | 2018 | 1755 | 0.030 |
Why?
|
| Benchmarking | 1 | 2019 | 1057 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2017 | 890 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1995 | 481 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 4428 | 0.030 |
Why?
|
| Models, Educational | 1 | 2015 | 375 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2008 | 4850 | 0.030 |
Why?
|
| Schools | 1 | 2021 | 1498 | 0.030 |
Why?
|
| Tetraethylammonium | 1 | 1991 | 55 | 0.020 |
Why?
|
| Rana catesbeiana | 1 | 1991 | 85 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 20762 | 0.020 |
Why?
|
| Isotonic Solutions | 1 | 1991 | 119 | 0.020 |
Why?
|
| Comorbidity | 2 | 2017 | 10590 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 39354 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 1995 | 948 | 0.020 |
Why?
|
| Solutions | 1 | 1991 | 409 | 0.020 |
Why?
|
| Leadership | 1 | 2020 | 1397 | 0.020 |
Why?
|
| Preoperative Period | 1 | 2012 | 565 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 18349 | 0.020 |
Why?
|
| Pacemaker, Artificial | 1 | 2015 | 828 | 0.020 |
Why?
|
| Inpatients | 1 | 2021 | 2566 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2009 | 198 | 0.020 |
Why?
|
| Comparative Effectiveness Research | 1 | 2014 | 714 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 10397 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2015 | 1260 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 1991 | 628 | 0.020 |
Why?
|
| Adult | 3 | 2017 | 223646 | 0.020 |
Why?
|
| Teaching | 1 | 2015 | 1171 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 3436 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2020 | 10099 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2006 | 5432 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 2080 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2014 | 2125 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 8052 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 3706 | 0.010 |
Why?
|
| Arginine | 1 | 2008 | 932 | 0.010 |
Why?
|
| Action Potentials | 1 | 1991 | 1838 | 0.010 |
Why?
|
| Medication Adherence | 1 | 2015 | 2187 | 0.010 |
Why?
|
| Middle Aged | 5 | 2017 | 223487 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2014 | 9669 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 13586 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 12077 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3251 | 0.010 |
Why?
|
| Logistic Models | 1 | 2014 | 13290 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2008 | 1982 | 0.010 |
Why?
|
| Radiography | 1 | 2009 | 6986 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2013 | 9384 | 0.010 |
Why?
|
| beta-Adrenergic Receptor Kinases | 1 | 1995 | 10 | 0.010 |
Why?
|
| Bucladesine | 1 | 1995 | 118 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1995 | 826 | 0.010 |
Why?
|
| Kidney | 1 | 2009 | 7064 | 0.010 |
Why?
|
| Cricetulus | 1 | 1995 | 812 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 89169 | 0.010 |
Why?
|
| Eye Proteins | 1 | 1995 | 628 | 0.010 |
Why?
|
| Cricetinae | 1 | 1995 | 2423 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 30009 | 0.010 |
Why?
|
| DNA Primers | 1 | 1995 | 2828 | 0.010 |
Why?
|
| Antigens | 1 | 1995 | 1443 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 54924 | 0.000 |
Why?
|
| Base Sequence | 1 | 1995 | 12422 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1995 | 8316 | 0.000 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 1984 | 88 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1995 | 13422 | 0.000 |
Why?
|
| Alzheimer Disease | 1 | 1984 | 8759 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 17623 | 0.000 |
Why?
|
| Gene Expression | 1 | 1995 | 7601 | 0.000 |
Why?
|
| Psychological Tests | 1 | 1984 | 643 | 0.000 |
Why?
|
| Cell Line | 1 | 1995 | 15602 | 0.000 |
Why?
|